Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH	Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms	Recruiting	Phase 2	2026-08-26		NCT07335601

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Madrigal Pharmaceuticals, Inc.	9

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Dallas Methodist	Dallas	United States	1
Houston Methodist Hospital	Houston	United States	260
Intermountain Medical Center	Murray	United States	142
Mayo Clinic	Rochester	United States	664
MedStar Georgetown University Hospital	Washington D.C.	United States	204
Northwell Health Inc, Center for Liver Disease and Transplantation	Manhasset	United States	2
Northwestern University	Chicago	United States	11
NY Presbyterian- Weill Cornell Medicine	New York	United States	1
The University of Chicago Medicine	Chicago	United States	14
University Health Network - Toronto General Hospital (TGH)	Toronto	Canada	1
University of California Los Angeles Medical Center	Los Angeles	United States	4
University of California San Diego	La Jolla	United States	39
University of California, San Francisco	San Francisco	United States	294
University of Colorado	Aurora	United States	147
University of Nebraska	Omaha	United States	1
University of Virginia Health System	Charlottesville	United States	34
Vanderbilt University Medical Center (VUMC)	Nashville	United States	2